Yuyu Pharma Inc (000227) — Cash Flow-to-Debt Ratio
Yuyu Pharma Inc (000227) has a Cash Flow-to-Debt Ratio of 0.01x as of September 2025, meaning its operating cash flow of ₩836.62 Million could theoretically repay 0% of its total liabilities (₩63.32 Billion) in one year. See Yuyu Pharma Inc free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Yuyu Pharma Inc Cash Flow-to-Debt Ratio (2014–2024)
Historical debt coverage capacity for Yuyu Pharma Inc across 11 annual periods. For the full cash flow conversion analysis, see how efficiently does Yuyu Pharma Inc generate cash.
Annual Cash Flow-to-Debt Ratio for Yuyu Pharma Inc (2014–2024)
Year-by-year debt coverage analysis for Yuyu Pharma Inc. Check 000227 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.34x | ₩24.95 Billion | ₩72.62 Billion | ▲ +6255.6% |
| 2023 | 0.01x | ₩420.86 Million | ₩77.86 Billion | ▲ +106.2% |
| 2022 | -0.09x | ₩-6.23 Billion | ₩71.83 Billion | ▼ -223.7% |
| 2021 | 0.07x | ₩4.51 Billion | ₩64.30 Billion | ▲ +199.5% |
| 2020 | -0.07x | ₩-2.67 Billion | ₩37.86 Billion | ▼ -125.2% |
| 2019 | 0.28x | ₩13.19 Billion | ₩47.17 Billion | ▲ +121.2% |
| 2018 | 0.13x | ₩6.11 Billion | ₩48.35 Billion | ▲ +770.2% |
| 2017 | 0.01x | ₩561.35 Million | ₩38.66 Billion | ▼ -95.1% |
| 2016 | 0.30x | ₩9.82 Billion | ₩33.01 Billion | ▲ +177.9% |
| 2015 | -0.38x | ₩-11.68 Billion | ₩30.60 Billion | ▼ -937.8% |
| 2014 | 0.05x | ₩1.36 Billion | ₩29.91 Billion | — |